张朝再, 董雷, 牟凤辉, 杨晓虹, 孙薇. 神经型一氧化氮合酶抑制剂的研究进展J. 药学学报, 2014,49(6): 781-788.
引用本文: 张朝再, 董雷, 牟凤辉, 杨晓虹, 孙薇. 神经型一氧化氮合酶抑制剂的研究进展J. 药学学报, 2014,49(6): 781-788.
ZHANG Chao-zai, DONG Lei, MU Feng-hui, YANG Xiao-hong, SUN Wei. Progress in the studies on neuronal nitric oxide synthase inhibitorsJ. Acta Pharmaceutica Sinica, 2014,49(6): 781-788.
Citation: ZHANG Chao-zai, DONG Lei, MU Feng-hui, YANG Xiao-hong, SUN Wei. Progress in the studies on neuronal nitric oxide synthase inhibitorsJ. Acta Pharmaceutica Sinica, 2014,49(6): 781-788.

神经型一氧化氮合酶抑制剂的研究进展

Progress in the studies on neuronal nitric oxide synthase inhibitors

  • 摘要: 一氧化氮(nitric oxide,NO)是生物体内一种重要的生物活性物质,可以参与心血管系统、神经系统、免疫系统、生殖系统和消化系统等多种生理活动的调节。在正常生理条件下,神经型一氧化氮合酶(nNOS)能精确调控神经系统中NO的产生、释放、扩散与灭活。但nNOS过度激活,可能产生过量的NO,与脑缺血损伤、阿尔兹海默症及帕金森症等神经系统疾病的发生、发展有着密切的关系,抑制nNOS的活性可以调节体内NO的含量,从而对一些神经系统疾病产生治疗作用。本文主要对nNOS的结构、调控及近年来小分子nNOS抑制剂的研究进展进行综述。

     

    Abstract: Nitric oxide (NO), which is involved in the regulation of the cardiovascular system, nervoussystem, immune system, reproductive system, digestive system and other physiological activities, is an important biological substance with activity.Under normal physiological conditions, neuronal nitric oxide synthase (nNOS) can precisely regulate the nervous system NO production, release, diffusion and inactivation processes.But an excess of NO associates with the development of cerebral ischemia, Alzheimer's and Parkinson's psychosis nervous system diseases, while inhibition of nNOS activity can regulate the content of NO in vivo, and produce a therapeutic effect on some of the nervous system diseases.This review mainly describes the structure and regulation of nNOS and recent developments of small molecule inhibitors of nNOS.

     

/

返回文章
返回